ONCOLYTIC MYXOMA VIRUS EXPRESSING FAST P14 TO TREAT HEMATOLOGICAL CANCER Application EP-3946373-A4 European Patent Office 11 Jan 2023
AN IMMUNE CHECKPOINT-MODULATING VSV-NDV HYBRID VIRUS FOR ONCOLYTIC VIRUS IMMUNOTHERAPY OF… Application WO-2022090500-A1 World Intellectual Property Organisation (WIPO) 05 May 2022
AN IMMUNE CHECKPOINT-MODULATING VSV-NDV HYBRID VIRUS FOR ONCOLYTIC VIRUS IMMONOTHERAPY OF… Application EP-3991741-A1 European Patent Office 04 May 2022
COMBINATION OF ONCOLYTIC VIRUS AND MODIFIED IMMUNE CELLS FOR TREATMENT OF TUMORS Application WO-2022057904-A1 World Intellectual Property Organisation (WIPO) 24 Mar 2022
RECOMBINANT VACCINIA VIRUS AND PHARMACEUTICAL COMPOSITION COMPRISING SAME Application EP-3741845-A4 European Patent Office 01 Dec 2021